THISH WILL BE A MULTIBAGGER STOCK IN LONG RUN KEEP MY WORDS
Results seem pretty decent to me. Flat topline and bottomline moves from negative to positive. Good news is the Proyurveda vertical doing good in both topline as well as bottomline.
Pharma has made 3 times revenue in the last quarter, going by same figure if Pharma can make 28cr revenue in 2016-17 should be great, on the 8.57 and 10.57 figure i added other income the figue came to 10.52 but in statement it is 10.57 can raise to CS on the break up , YOY even pharma revenue is down a bit but NP seems to be postive, it will take another year or to see the pharma benefits..